SKARNA MEDICAL LIMITEDActive

Company number 07349385Private limited companyIncorporated 2010

Key figures

£924,543+33.9%
Net assets 2024/25
+30.2%
Average annual growth 2020/21–2024/25
0250 k500 k750 k1 m2020/212021/222022/232023/242024/25

Like most small UK companies, SKARNA MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Total assets—1,417,791—1,982,7422,348,084
Total liabilities———1,291,3721,421,993
Net assets / total equity321,246387,062506,552690,296924,543
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

68209

As described in the company's latest filed accounts.

Summary: SKARNA MEDICAL LIMITED

Company

SKARNA MEDICAL LIMITED is a private limited company registered with Companies House under company number 07349385. It was incorporated on 18 Aug 2010. Its status is active. The registered office is in North finchley (N12). Its nature of business (SIC 2007) is other letting and operating of own or leased real estate (68209), general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files micro-entity accounts. Net assets were £924,543, up 33.9% on the previous year. Total assets were £2,348,084 and total liabilities £1,421,993. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

2 persons with significant control are registered. 4 of 4 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 May 2027. The next confirmation statement is due by 24 Jul 2027.